Do Koalas Have Chlamydia? Understanding the Disease Threatening Australia's Iconic Marsupial

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on February 3rd, 2026.

Key Takeaways

  • Koalas can contract two types of chlamydia that seriously impact their health

  • The disease can cause blindness, infertility, and increased vulnerability to other threats

  • Infection rates vary widely, from 0% to nearly 90% in different populations

  • Researchers are actively working on vaccine and management strategies

Chlamydia in koalas is more than just an interesting medical curiosity. It's a critical health challenge threatening the survival of these beloved Australian marsupials. While the idea might sound shocking, chlamydia is a serious medical condition that can devastate koala populations across Australia.

The disease is primarily caused by two bacterial strains: Chlamydia pecorum and Chlamydia pneumoniae. Of these, Chlamydia pecorum is the most prevalent and problematic form, causing significant health issues for koalas in the wild.

How Chlamydia Spreads in Koala Populations

Chlamydiosis predominantly spreads during mating or through close physical contact between koalas. Young koalas can also become infected during birth or while in their mother's pouch. Unlike human chlamydia, this version is particularly aggressive and can remain asymptomatic for years before causing serious health complications.

Symptoms and Impact of Chlamydia in Koalas

The disease manifests in several devastating ways. Koalas can experience:

  • Keratoconjunctivitis, causing eye inflammation and potential blindness

  • Urinary tract infections resulting in 'wet bottom' syndrome

  • Reproductive tract infections leading to infertility

  • Increased susceptibility to other environmental threats

Pneumonia cough symptoms can sometimes be confused with chlamydia-related respiratory issues, making diagnosis challenging for wildlife veterinarians.

Prevalence and Population Impact

Infection rates are alarmingly variable. Some koala populations show 0% infection, while others experience rates up to 90%. Research indicates that approximately two-thirds of infected, asymptomatic koalas will develop clinical signs within four years.

Current Research and Management Strategies

Scientists and government agencies are taking multiple approaches to address this health crisis:

Vaccine Development

Researchers have conducted several vaccine trials, though complete protection remains elusive. A recent trial vaccinated 53 koalas, but four still contracted chlamydia within six months, highlighting the complex nature of the disease.

Monitoring and Intervention

The New South Wales Government has launched comprehensive monitoring programs, including:

  • A koala sentinel program

  • Statewide disease monitoring initiatives

  • Drone surveys to track infection rates

Comparative Disease Prevalence

Population

Chlamydia Infection Rate

Key Characteristics

South-West Sydney

Emerging

Recently discovered infection

Southern Highlands

40-60%

Established population impact

Northern Rivers

Variable

Active research zone

Frequently Asked Questions

While not always immediately fatal, the disease can significantly reduce a koala's quality of life and survival chances.

The strains are different from human chlamydia, but close contact with infected koalas can pose transmission risks.

Ongoing vaccine trials and population monitoring are the primary strategies.

Eye inflammation, urinary tract issues, and reproductive complications are the most common symptoms.

Infection rates vary dramatically, from 0% to nearly 90% in different koala populations.

The Bottom Line

Koala chlamydia represents a complex and serious threat to these iconic marsupials. Ongoing research and management strategies offer hope for controlling this devastating disease.

Ready to meet your AI doctor? Get started with Doctronic today.

Related Articles